Phase 3

Novo Nordisk's Once-Weekly Insulin Icodec Shows Favorable Reduction In HbA1c In Type 2 Diabetes
InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
Pfizer-BioNTech COVID-19 Shot Safe, Effective Through Six Months After Second Dose
Chiasma's Mycapssa Improves Acromegaly Related Symptoms After Switching From iSRLs

Phase 3 Recent News

PhaseBio Recruits BioVectra As Manufacturing Partner For Bentracimab
PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) 
Roche's Tocilizumab, Gilead's Remdesivir Combo Fails To Improve Hospital Discharge Time in COVID-19 Study
Roche Holdings AG (OTCQX: RHHBY) has 
Vir/GSK's COVID-19 Antibody Therapy Cuts Hospitalization, Deaths by 85%, Seeks FDA Emergency Use Nod
An Independent Data Monitoring Committee (IDMC) has recommended that the Phase 3 COMET-ICE trial, evaluating VIR-7831 (GSK4182136) as monotherapy for COVID-19, 
Eli Lilly's Tirzepatide Tops Novo's Semaglutide In Late-Stage Diabetes Study
Eli Lilly & Co (NYSE: LLY) has reported 
Vascular Biogenics' Ovarian Cancer Gene Therapy Shows Response Rate Of Over 58%
BioXcel's BXCL501 Lower Dose Shows Statistical Significance On Agitation Scales
BioXcel Therapeutics Inc (NASDAQ: BTAI) 
Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder
Eli Lilly and Co (NYSE: LLY) and Incyte Corporation (NASDAQ: 
United Therapeutics Pulls Plug On Trevyent Development
Based on the FDA’s written comments, United Therapeutics Corporation (NASDAQ: UTHR) has 
Ocugen Shares Are Trading Higher On Its Partner's COVID-19 Vaccine Candidate Showing 81% Efficacy
Ocugen Inc (NASDAQ: OCGN) shares soared in the premarket on heavy volume after Bharat Biotech, the company's COVID-19 vaccine development partner in India, 
Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May
Novavax Inc’s (NASDAQ: NVAX) COVID-19 shot can probably win FDA emergency use nod as early as May, said the company’s CEO Stanley Erck, 
Glaukos' iLink Therapy Meets Primary Endpoint In Late-Stage Vision Disorder Study
Karyopharm's Partner Antengene Receives Priority Review For Selinexor Application In China
RedHill Biopharma, Cosmo Pharma In Manufacturing Pact for Movantik, RHB-204
Seagen/Astellas Pharma Seek Approval For PADCEV's Expanded Use In Urothelial Cancer Settings
Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials
Opdivo Plus Cabometyx Combo Shows Superior Clinical Benefit Versus Sunitinib In Late-Stage Kidney Cancer Study
Janssen's Erleada Plus, Zytiga Plus Prednisone Combo Treatment Shows Clinical Benefit In Late-Stage Prostate Cancer Study
Veru's COVID-19 Drug Candidate Shows High Relative Reduction In Treatment Failures, Mortality In Mid-Stage Study
Calliditas Starts Dosing In Nefecon Open Label Extension Study In Kidney Disease
Otonomy Rips 90% After Meniere's Disease Drug Achieves Primary Endpoint
Rigorous Trial Design, Nice Risk/Reward Keep Analyst Anxious For Avoxant's Phase 3 MINDSET Data
Galena Shares Up 50% On Regulatory Pathway For Thrombosis Treatment
Getting Into The Drug Business: From NDAs To PDUFA Dates